ASURAGEN INC.

In News

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Size - Market.us

Market.us - Nov 11, 2025

Bio-Techne to Acquire Asuragen - PR Newswire

PR Newswire - Mar 03, 2021

Minimal Residual Disease Testing Market is Expected to Reach $2.3 Billion | MarketsandMarkets - The Globe and Mail

The Globe and Mail - Apr 08, 2025

Bio-Techne to Acquire Asuragen for $320M - Medical Product Outsourcing

Medical Product Outsourcing - Mar 04, 2021

Press Release Service: mRNA Platform Global Strategic Research Report 2024: Increasing Prevalence of Infectious & Chronic Conditions to Unleash Gains & Help mRNA Vaccines Market Gallop Ahead - Forecast to 2030 - ResearchAndMarkets.co - CRISPR Medicine News

CRISPR Medicine News - Jul 11, 2024

Bio-Techne Agrees to Buy Texas Testing Company for Up to $320M - Twin Cities Business

Twin Cities Business - Mar 03, 2021

Fragile X Added to Newborn Screening in North Carolina Via Early Check Study - Fragile X News Today

Fragile X News Today - Oct 30, 2018

Yale Scientists Show that a microRNA Can Reduce Lung Cancer Growth - YaleNews

YaleNews - Mar 20, 2008

Health Canada approves two tests for CML patients - MDEdge

MDEdge - Nov 15, 2018

Roche acquiring Genmark in $1.8B merger - BioWorld MedTech

BioWorld MedTech - Mar 15, 2021

ESR1 Mutated Metastatic Breast Cancer Diagnostics Market - Future Market Insights

Future Market Insights - Aug 26, 2025

Prolias Blames PDI For Sinking Cornell Licensing Deal - Law360

Law360 - Apr 22, 2015

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment